Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Concord Medical Co., Ltd. (6518:TWSE), powered by AI.
Concord Medical Co., Ltd. is currently trading at $30.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Concord Medical Co., Ltd. on Alpha Lenz.
View Concord Medical Co., Ltd.'s valuation metrics on Alpha Lenz.
“Concord Medical Co., Ltd.'s ROE is 9.5%. Explore profitability and growth together.”
Ask for details →Concord Medical Co., Ltd. is a healthcare services company specializing in hospital management support in Taiwan. Founded in 2009 and headquartered in New Taipei City, it delivers a suite of medical management solutions, including staff training and nursing workforce services, as well as strategic consulting for hospital operations. The company is notable for its procurement services, handling the supply of medical instruments, equipment, consumables, and reagents to healthcare providers. It also develops and markets medical beauty care products, health foods, and finished Chinese medicine offerings under its own brand. Beyond procurement, Concord Medical manages planning and sales of medical equipment, and offers equipment leasing services, helping hospitals and clinics optimize their infrastructure efficiently. Operating within the broader healthcare sector, Concord Medical plays an essential role in enabling medical institutions to enhance patient care while streamlining operations and access to critical resources in Taiwan’s evolving healthcare environment.
“Concord Medical Co., Ltd.'s ROE is 9.5%. Explore profitability and growth together.”
Ask for details →Concord Medical Co., Ltd. (ticker: 6518) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).
The current price is 30 with a P/E ratio of -x and P/B of -x.
ROE is 9.45% and operating margin is 7.55%. Annual revenue is $964M.